For the 29,000 patients in the United States with metastatic colorectal cancer, chemotherapy with irinotecan is a yardstick care that has been shown to improve survival. But for more than one in 10 of these patients, a third edition by the editors of the american heritage® dictionary. copyright © 2003 in their DNA means that this regimen could result in a severe reduction in their white blood cell count, leading to a high risk of bacterial insanitation and viable subsequent death.

More: - Brought to my attention by